AVRDB
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Anteris Technologies Global Corp.
π¦πΊ ASX
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
+ 2519.76%
Annual Growth
5 years average annual capital growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
5
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Anteris Technologies Global Corp.
π Performance
Price History
+9481.82%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$10.54
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in AVRDB
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in AVRDB
N/A
AVRDB investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in AVRDB also invest in...
Anteris Technologies Ltd. is a structural heart company, which engages in research, develops, commercializes, and distributes medical technologies and devices. The company is headquartered in Eagan, Minnesota. The company went IPO on 2024-12-13. The company is engaged in the research and development of its biomimetic technology (ADAPT, DurAVR Transcatheter Heart Valve (THV), ComASUR Transfemoral Delivery System) to address unmet medical needs in the treatment of aortic stenosis. The DurAVR THV, with its single piece, native-shaped biomimetic design is built to mimic the performance of a healthy aortic valve and to restore normal laminar (smooth) blood flow. This class of technology can be used to treat new aortic stenosis patients and to treat aortic stenosis patients with failed valves (valve-in-valve). ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. ComASUR is its balloon-expandable delivery system.
π Performance (5Yr p.a)
-5.10%
π Share price
$4.88 AUD
π©Ί HEALTH CARE
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
9.21%
π Share price
$96.73 AUD
πΈ FINANCIALS
π¦πΊ AUSTRALIA
β³οΈ DIVERSIFIED
π§± MATERIALS
π HIGH PRICE GROWTH
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
13.19%
π Share price
$123.50 AUD
π GLOBAL
β³οΈ DIVERSIFIED
π€ TECHNOLOGY
π HIGH PRICE GROWTH
CRYP.AX was created on 2021-11-02 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. CRYP.AX aims to track the performance of an Index (before fees and expenses) that provides exposure to global companies at the forefront of the crypto economy.
π Share price
$4.82 AUD
πΈ FINANCIALS
π€ TECHNOLOGY
Wesfarmers Ltd. engages in the provision of fresh food, groceries, general merchandise, liquor, fuel, and financial services. The company is headquartered in Perth, Western Australia and currently employs 120,000 full-time employees. Its segments include Bunnings Group; Kmart Group; Officeworks; Wesfarmers Chemicals, Energy and Fertilisers (WesCEF); Industrial and Safety; Health; Catch; and Other. The Bunnings Group segment is a retailer of building materials and home, garden and lifestyle improvement products. The Kmart Group segment is a retailer of apparel and general merchandise, including toys, leisure, entertainment, home, and consumables. The Officeworks segment is a retailer and supplier of office products and solutions for households, small-to-medium sized businesses, and the education sector. The WesCEF segment is a manufacturer and marketer of chemicals for industry, mining, and mineral processing; manufacturer and marketer of broadacre and horticultural fertilizers; and others.
π Performance (5Yr p.a)
22.16%
π Share price
$74.44 AUD
π³ ENVIRONMENTAL
ποΈ CONSUMER
π HIGH ESG SCORE
ποΈ SOCIALLY AWARE
π HIGH PRICE GROWTH
Want more shares? Try these...